Metabasis Therapeutics and Merck Announce Collaboration to Develop New Treatment for Diabetes, Hyperlipidemia and Obesity
29-Jun-2005 -
Metabasis Therapeutics, Inc. and Merck & Co., Inc. announced that they have formed a collaboration to research, develop and commercialize novel small molecule therapeutics with potential to treat several diseases, including type 2 diabetes, hyperlipidemia and obesity, by activation of an enzyme ...
adenosine monophosphate
cholesterol
diseases
+7